Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Combining geodiversity with climate and topography to account for threatened species richness.

Tukiainen H, Bailey JJ, Field R, Kangas K, Hjort J.

Conserv Biol. 2017 Apr;31(2):364-375. doi: 10.1111/cobi.12799. Epub 2016 Nov 10.

PMID:
27476459
2.

Effect of weight loss on inflammation in patients with mild obstructive sleep apnea.

Sahlman J, Seppä J, Herder C, Peltonen M, Peuhkurinen K, Gylling H, Vanninen E, Tukiainen H, Punnonen K, Partinen M, Uusitupa M, Tuomilehto H.

Nutr Metab Cardiovasc Dis. 2012 Jul;22(7):583-90. doi: 10.1016/j.numecd.2010.10.007. Epub 2010 Dec 28.

PMID:
21193295
3.

Sustained improvement in mild obstructive sleep apnea after a diet- and physical activity-based lifestyle intervention: postinterventional follow-up.

Tuomilehto H, Gylling H, Peltonen M, Martikainen T, Sahlman J, Kokkarinen J, Randell J, Tukiainen H, Vanninen E, Partinen M, Tuomilehto J, Uusitupa M, Seppä J; Kuopio Sleep Apnea Group.

Am J Clin Nutr. 2010 Oct;92(4):688-96. doi: 10.3945/ajcn.2010.29485. Epub 2010 Aug 11.

PMID:
20702607
4.

Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea.

Tuomilehto HP, Seppä JM, Partinen MM, Peltonen M, Gylling H, Tuomilehto JO, Vanninen EJ, Kokkarinen J, Sahlman JK, Martikainen T, Soini EJ, Randell J, Tukiainen H, Uusitupa M; Kuopio Sleep Apnea Group.

Am J Respir Crit Care Med. 2009 Feb 15;179(4):320-7. doi: 10.1164/rccm.200805-669OC. Epub 2008 Nov 14.

PMID:
19011153
5.

Effect of weight reduction on rhinometric measurements in overweight patients with obstructive sleep apnea.

Kemppainen T, Ruoppi P, Seppä J, Sahlman J, Peltonen M, Tukiainen H, Gylling H, Vanninen E, Tuomilehto H.

Am J Rhinol. 2008 Jul-Aug;22(4):410-5. doi: 10.2500/ajr.2008.22.3203.

PMID:
18702908
6.
7.

Aspergillus fumigatus challenge increases cytokine levels in nasal lavage fluid.

Stark H, Roponen M, Purokivi M, Randell J, Tukiainen H, Hirvonen MR.

Inhal Toxicol. 2006 Dec;18(13):1033-9.

PMID:
16966303
8.

Experimental PVC material challenge in subjects with occupational PVC exposure.

Tuomainen A, Stark H, Seuri M, Hirvonen MR, Linnainmaa M, Sieppi A, Tukiainen H.

Environ Health Perspect. 2006 Sep;114(9):1409-13.

9.

Short-term and seasonal variations of exhaled and nasal NO in healthy subjects.

Stark H, Purokivi M, Kiviranta J, Randell J, Tukiainen H.

Respir Med. 2007 Feb;101(2):265-71. Epub 2006 Jun 22.

10.

Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients.

Kannisto S, Laatikainen A, Taivainen A, Savolainen K, Tukiainen H, Voutilainen R.

Eur J Endocrinol. 2004 May;150(5):687-90.

PMID:
15132725
11.

The remediation of mold damaged school--a three-year follow-up study on teachers' health.

Patovirta RL, Husman T, Haverinen U, Vahteristo M, Uitti JA, Tukiainen H, Nevalainen A.

Cent Eur J Public Health. 2004 Mar;12(1):36-42.

PMID:
15068207
12.

Inhalation challenge with bovine dander allergens: who needs it?

Koskela H, Taivainen A, Tukiainen H, Chan HK.

Chest. 2003 Jul;124(1):383-91.

PMID:
12853550
13.

Nitric oxide alone is an insufficient biomarker of exposure to microbes in a moisture-damaged building.

Purokivi M, Hirvonen MR, Randell J, Roponen M, Tukiainen H.

Inhal Toxicol. 2002 Dec;14(12):1279-90.

PMID:
12454791
14.

Threshold levels of purified natural Bos d 2 for inducing bronchial airway response in asthmatic patients.

Zeiler T, Taivainen A, Mäntyjärvi R, Tukiainen H, Rautiainen J, Rytkönen-Nissinen M, Virtanen T.

Clin Exp Allergy. 2002 Oct;32(10):1454-60.

PMID:
12372125
15.

Comparison of inflammatory elements in nasal lavage and induced sputum following occupational exposure to moldy-building microbes.

Purokivi M, Hirvonen MR, Roponen M, Randell J, Vahteristo M, Tukiainen H.

Inhal Toxicol. 2002 Jun;14(6):653-62.

PMID:
12119074
16.

Safety, tolerability and acceptability of two dry powder inhalers in the administration of budesonide in steroid-treated asthmatic patients.

Tukiainen H, Rytilä P, Hämäläinen KM, Silvasti MS, Keski-Karhu J; Finnish Study Group.

Respir Med. 2002 Apr;96(4):221-9.

17.

Inflammatory mediators in nasal lavage, induced sputum and serum of employees with rheumatic and respiratory disorders.

Roponen M, Kiviranta J, Seuri M, Tukiainen H, Myllykangas-Luosujärvi R, Hirvonen MR.

Eur Respir J. 2001 Sep;18(3):542-8.

18.
19.

Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland.

Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Kleemola M, Koskela M, Leinonen M, Rönnberg PR, Saikku P, Stén M, Tarkiainen A, Tukiainen H, Pyörälä K, Mäkelä PH.

Clin Infect Dis. 2001 Apr 15;32(8):1141-54. Epub 2001 Mar 23.

PMID:
11283803
20.

Long-term economic evaluation of intensive patient education during the first treatment year in newly diagnosed adult asthma.

Kauppinen R, Vilkka V, Sintonen H, Klaukka T, Tukiainen H.

Respir Med. 2001 Jan;95(1):56-63.

Supplemental Content

Loading ...
Support Center